SCHEMBL3119147

SCHEMBL3119147

COc1cc(CO)ccc1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.56
POLB P06746 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
ACHE P22303 1/20 0.46
CA2 P00918 3/20 0.44
CA1 P00915 2/20 0.43
CA9 Q16790 2/20 0.43
CA12 O43570 1/20 0.43
HTT P42858 1/20 0.43
FYN P06241 1/20 0.43
TTR P02766 1/20 0.42
KDM4E B2RXH2 2/20 0.40
GAA P10253 1/20 0.40
ATM Q13315 1/20 0.40
ALDH1A1 P00352 2/20 0.40
LDHA P00338 1/20 0.40
SHBG P04278 2/20 0.39
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL499011 0.94 DRD2 (0.50) DRD2POLBNPC1RAB9AACHE
SCHEMBL9959545 0.85 DRD2 (0.48) DRD2POLBNPC1RAB9AHTT
SCHEMBL6663695 0.84 DRD2 (0.53) DRD2POLBCA2HTTKDM4E
SCHEMBL3113521 0.84 DRD2 (0.41) DRD2POLBNPC1RAB9AHTT
SCHEMBL7484802 0.83 DRD2 (0.61) DRD2NPC1HTTGAAALDH1A1
SCHEMBL29565908 0.83 DRD2 (0.55) DRD2POLBCA2CA1CA9
SCHEMBL9452824 0.83 DRD2 (0.41) DRD2POLBNPC1RAB9AACHE
SCHEMBL1635299 0.83 DRD2 (0.51) DRD2POLBCA2CA1CA9
SCHEMBL26491007 0.83 DRD2 (0.43) DRD2POLBNPC1RAB9AACHE
SCHEMBL21359165 0.82 DRD2 (0.64) DRD2NPC1CA2CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230137943-A1 PHOTOPROXIMITY PROFILING OF PROTEIN-PROTEIN INTERACTIONS IN CELLS THE UNIVERSITY OF CHICAGO 2023-05-04 US disclosed
US-20100256413-A1 METHOD FOR THE CHEMICAL SYNTHESIS OF CAPSINOIDS UNIVERSIDAD DE CÁDIZ (ES) 2010-10-07 US disclosed
EP-2149548-A1 METHOD FOR THE CHEMICAL SYNTHESIS OF CAPSINOIDS Universidad De Cádiz (ES) 2010-02-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256413-A1 METHOD FOR THE CHEMICAL SYNTHESIS OF CAPSINOIDS CES2, ACACB, TES DRD2 908/4885POLB 2651/4885NPC1 980/4885
US-20230137943-A1 PHOTOPROXIMITY PROFILING OF PROTEIN-PROTEIN INTERACTIONS IN CELLS PPIA, S100A4, S100A6 DRD2 4707/4885POLB 2430/4885NPC1 4881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.